MétaCan
ENFR
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

Export CSVExport JSONAPI query

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Topic
Biosimilars and Bioanalytical Methods
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

876 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
876 works in the cohort · of 4,299,418page 13 of 18

Labels cover 4 of 876 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 876 of 876 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

fundno affno abstractunlabeled
AB0197 EFFICACY AND SAFETY OF HLX01 COMBINED WITH METHOTREXATE IN CHINESE PATIENTS WITH MODERATELY TO SEVERELY ACTIVE RHEUMATOID ARTHRITIS WHO HAD INADEQUATE RESPONSES TO METHOTREXATE: RESULTS OF A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY
Xiaofeng Zeng, Juanlan Liu, X. Liu, Lijun Wu, Yiqiong Liu, X Liao +12 more
2021· article· en· Annals of the Rheumatic Diseases· Immunology and Microbiology
distilled prediction:candidate · noneconsensus · none
0
citations
affunlabeled
REVIEW ARTICLE ELISA: THE IMMUNOLOGICAL DIGNOSTIC TOOL
Atharv M. Bajare, Yash S. Bandal, Mrudula R. Gole, Shradha A. Kadam, Abhishek R. Auti, Anjum N. Hasnain
2023· article· en· IARJSET· Immunology and Microbiology
distilled prediction:candidate · insufficient_payloadconsensus · insufficient_payload
0
citations
venueno affno abstractunlabeled
Patch Testing Patients On Etanercept
Ellen K. Roh, Matthew Zirwas
2006· article· en· Dermatitis· Immunology and Microbiology
distilled prediction:candidate · insufficient_payloadconsensus · none
0
citations
venueno affno abstractunlabeled
10.1016/b978-0-443-10303-2.50022-9
2000· book-chapter· en· Time to knit· Immunology and Microbiology
distilled prediction:candidate · metaepi_narrow+research_integrity+insufficient_payloadconsensus · insufficient_payload
0
citations
affno abstractunlabeled
THU0138 Secondary Efficacy Results Up To Week 24 from A Phase III Study Comparing SB5 (An Adalimumab Biosimiar) with Adalimumab Reference Product in Patients with Moderate To Severe Rheumatoid Arthritis despite Methotrexate Therapy
Jonathan Kay, Michael E. Weinblatt, Edward Keystone, Mark C. Genovese, Asta Baranauskaitė, Soo Yeon Cheong +1 more
2016· article· en· Annals of the Rheumatic Diseases· Immunology and Microbiology
distilled prediction:candidate · metaepi_narrowconsensus · none
0
citations
venueno affno abstractunlabeled
10.1016/s0765-2046(98)80159-7
2000· article· en· Time to knit· Immunology and Microbiology
distilled prediction:candidate · insufficient_payloadconsensus · insufficient_payload
0
citations
venueno affno abstractunlabeled
10.1016/s1541-9800(06)71295-9
2000· article· en· Time to knit· Immunology and Microbiology
distilled prediction:candidate · insufficient_payloadconsensus · insufficient_payload
0
citations
aboutno affunlabeled
Dried blood spot (DBS) Collection for SARS-CoV-2 antibodies
Hans Vandenberghe, C. Naik, J. Ivica, K. Mackett, C. Marcotte, Dipak Patel +2 more
2021· article· en· Biopreservation and Biobanking· Immunology and Microbiology
distilled prediction:candidate · noneconsensus · none
0
citations
venueno affunlabeled
Sewage-Based Drug Epidemiology
Daniel A. Burgard
2014· article· en· Sound Ideas (University of Puget Sound)· Immunology and Microbiology
distilled prediction:candidate · insufficient_payloadconsensus · none
0
citations
aboutno affunlabeled
Безопасность биологических препаратов. Сообщение 2. Проблемы безопасности биоподобных препаратов
А. А. Солдатов, Ж. И. Авдеева, Ю. В. Олефир, В. А. Меркулов, В. П. Бондарев
2016· article· ru· Biological Products Prevention Diagnosis Treatment· Immunology and Microbiology
distilled prediction:candidate · metaepi_narrow+research_integrity+insufficient_payloadconsensus · metaepi_narrow+insufficient_payload
0
citations
venueno affno abstractunlabeled
10.1016/s1541-9800(12)70188-6
2000· article· en· Time to knit· Immunology and Microbiology
distilled prediction:candidate · insufficient_payloadconsensus · insufficient_payload
0
citations
venueno affno abstractunlabeled
10.1016/s1541-9800(07)70460-x
2000· article· en· Time to knit· Immunology and Microbiology
distilled prediction:candidate · insufficient_payloadconsensus · insufficient_payload
0
citations
affaboutunlabeled
Utilization of Biologics in Saskatchewan
Shenzhen Yao, Lisa M. Lix, Wenbin Li, Yvonne Shevchuk, Gary Teare, Anne Champagne +2 more
2017· article· en· Immunology and Microbiology
distilled prediction:candidate · noneconsensus · none
0
citations
affno abstractunlabeled
Der Cluster für Industrielle Biotechnologie – CLIB<sup>2021</sup>
Karl‐Erich Jaeger, Manfred Kircher
2021· book-chapter· de· Immunology and Microbiology
distilled prediction:candidate · metaepi_narrow+research_integrity+insufficient_payloadconsensus · metaepi_narrow+research_integrity+insufficient_payload
0
citations
← previousnext →

How this was built: Screen · Findings · About